Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Carr Edward sold 20,000 Dianthus Therapeutics, Inc. shares (Form 4)
Traded Sep 17, 2026 · Filed Sep 18, 2026
On Sep 17, 2026, Carr Edward (CHIEF ACCOUNTING OFFICER) sold 20,000 Dianthus Therapeutics, Inc. shares at an average US$101.38 for US$2.03M under a trading plan, leaving 0 shares. Filed Sep 18, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$101.38 average (US$100.43 to US$104.39)
- Value
- US$2.03M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF ACCOUNTING OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Common Stock | Option exercise | 20,000 | US$17.88 | 20,000 | Direct |
| Sep 17, 2026 | Common Stock | Sale | 7,928 | US$100.43 | 12,072 | Direct |
| Sep 17, 2026 | Common Stock | Sale | 6,771 | US$101.37 | 5,301 | Direct |
| Sep 17, 2026 | Common Stock | Sale | 3,501 | US$102.39 | 1,800 | Direct |
| Sep 17, 2026 | Common Stock | Sale | 1,100 | US$103.20 | 700 | Direct |
| Sep 17, 2026 | Common Stock | Sale | 700 | US$104.39 | 0 | Direct |
Source
Related
- Dianthus Therapeutics, Inc.
- Carr Edward
- Dianthus Therapeutics, Inc. shareholders
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · Wellington Management Group LLP · Aug 13, 2026